Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -7.761M
March 31, 2026 -610.88M
December 31, 2025 -3.415M
September 30, 2025 -0.306M
June 30, 2025 -3.235M
March 31, 2025 -6.049M
December 31, 2024 -19.20M
September 30, 2024 -1.515B
June 30, 2024 -110.37M
March 31, 2024 -818.20M
December 31, 2023 -6.611M
September 30, 2023 -48.55M
June 30, 2023 -546.97M
March 31, 2023 -41.56M
December 31, 2022 -657.49M
Date Value
September 30, 2022 -44.02M
June 30, 2022 -49.88M
March 31, 2022 -111.02M
December 31, 2021 -8.754M
September 30, 2021 -7.599M
June 30, 2021 -0.956M
March 31, 2021 -0.487M
December 31, 2020 -0.555M
September 30, 2020 -0.036M
June 30, 2020 -264.38M
March 31, 2020 -109.96M
December 31, 2019 -42.51M
September 30, 2019 -0.433M
June 30, 2019 -0.002M
March 31, 2019 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Moderna, Inc. -23.00M
Vir Biotechnology, Inc. -78.38M
Revolution Medicines, Inc. -1.688B
Arrowhead Pharmaceuticals, Inc. -29.86M
Oncolytics Biotech, Inc. -6.704M